Literature DB >> 28626272

Aripiprazole-induced Asymptomatic Hypertension: A Case Report.

Hilal Seven1, Medine Giynaş Ayhan1, Ayşe Kürkcü1, Süleyman Özbek1, İbrahim Eren1.   

Abstract

Aripiprazole is a second generation antipsychotic widely prescribed for the treatment of psychiatric diseases. It is generally known that antipsychotics have hypotensive effects. In this case report, however, we present the case of a medically healthy patient with schizophrenia who developed hypertension (HT) after the initiation of aripiprazole. The patient's blood pressure returned to normal after discontinuation of aripiprazole, suggesting that aripiprazole may have led to asymptomatic acute HT.

Entities:  

Keywords:  adverse effect; aripiprazole; hypertension

Mesh:

Substances:

Year:  2017        PMID: 28626272      PMCID: PMC5472172     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  10 in total

1.  Aripiprazole augmentation induced hypertension in major depressive disorder: a case report.

Authors:  Yi-Ling Hsiao; Shaw-Ji Chen; Tsu-Wang Shen; Chun-Hung Chang; Shao-Tsu Chen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-11-24       Impact factor: 5.067

2.  Hypertension and aripiprazole.

Authors:  Laurence Borras; E L Constant; A Eytan; Philippe Huguelet
Journal:  Am J Psychiatry       Date:  2005-12       Impact factor: 18.112

3.  Aripiprazole, hypertension, and confusion.

Authors:  William Pitchot; Marc Ansseau
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

4.  Aripiprazole and hypertension in adolescents.

Authors:  Flora Bat-Pitault; Richard Delorme
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-10       Impact factor: 2.576

Review 5.  Peripheral adrenergic receptors in hypertension.

Authors:  M C Michel; O E Brodde; P A Insel
Journal:  Hypertension       Date:  1990-08       Impact factor: 10.190

Review 6.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

7.  A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.

Authors:  Robert L Findling; Adelaide Robb; Margaretta Nyilas; Robert A Forbes; Na Jin; Svetlana Ivanova; Ronald Marcus; Robert D McQuade; Taro Iwamoto; William H Carson
Journal:  Am J Psychiatry       Date:  2008-09-02       Impact factor: 18.112

8.  Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.

Authors:  Paul E Keck; Joseph R Calabrese; Roger S McIntyre; Robert D McQuade; William H Carson; James M Eudicone; Berit X Carlson; Ronald N Marcus; Raymond Sanchez
Journal:  J Clin Psychiatry       Date:  2007-10       Impact factor: 4.384

9.  Worsened hypertension control induced by aripiprazole.

Authors:  Norio Yasui-Furukori; Akira Fujii
Journal:  Neuropsychiatr Dis Treat       Date:  2013-04-15       Impact factor: 2.570

Review 10.  Aripiprazole: from pharmacological profile to clinical use.

Authors:  Guido Di Sciascio; Marco Andrea Riva
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-13       Impact factor: 2.570

  10 in total
  4 in total

1.  Aripiprazole-induced Hepatitis: A Case Report.

Authors:  Lígia Castanheira; Elsa Fernandes; Pedro Levy; Ricardo Coentre
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-11-20       Impact factor: 2.582

2.  Hypertension Induced by Aripiprazole Use in an Autistic Child Patient.

Authors:  Aylin Deniz Uzun; Şermin Yalın Sapmaz; Masum Öztürk; Hasan Kandemir
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-11-20       Impact factor: 2.582

3.  Aripiprazole reduces liver cell division.

Authors:  Tinkara Pirc Marolt; Barbara Kramar; Klara Bulc Rozman; Dušan Šuput; Irina Milisav
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

Review 4.  Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone.

Authors:  Paula Soria-Chacartegui; Gonzalo Villapalos-García; Pablo Zubiaur; Francisco Abad-Santos; Dora Koller
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.